Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Lummen, C"'
Autor:
Honoré, N., Van Der Elst, A., Dietz, A., Van Marcke de Lummen, C., Helaers, R., Mendola, A., Dahou, H., Marbaix, E., Poncin, R., Seront, E., Schmitz, S., Limaye, N., Galot, R., Machiels, J-P.
Publikováno v:
In Immuno-Oncology and Technology December 2023 20 Supplement
Autor:
van der Elst, A., Herrero, D., Morfouace, M., Galot, R., Van Marcke de Lummen, C., Lucas, S., Machiels, J-P.
Publikováno v:
In Immuno-Oncology and Technology December 2022 16 Supplement 1
Autor:
Derouane, F., Van Marcke de Lummen, C., Ambroise, J., Berliere, M., Van Bockstal, M.R., Jerusalem, G., Bours, V., Josse, C., Corbet, C., Duhoux, F.P.
Publikováno v:
In Annals of Oncology October 2023 34 Supplement 2:S302-S302
Autor:
Dowlati, A., Cervantes, A., Babu, S., Hamilton, E.P., Wong, S.F., Tazbirkova, A., Sullivan, I.G., Van Marcke de Lummen, C., Italiano, A., Patel, J., Mekan, S., Wu, T., Chiang, A.C.
Publikováno v:
In Annals of Oncology October 2023 34 Supplement 2:S1061-S1062
Autor:
Aftimos, P.G., Punie, K., Decoster, L., Van Marcke de Lummen, C., Hebrant, A., Raicevic, G., Van Valckenborgh, E., Maes, B., Maetens, J., Collignon, J.J., van den Mooter, T.F.A., Fried-Vermeij, J., Demey, W., Tejpar, S., Peeters, M., Canon, J-L., Lybaert, W., Mebis, J., Rottey, S., De Grève, J.
Publikováno v:
In Annals of Oncology October 2023 34 Supplement 2:S253-S254
Autor:
Honoré, N., Van Marcke de Lummen, C., Galot, R., Helaers, R., van Maanen, A., Ambroise, J., Mendola, A., Dahou, H., Marbaix, E., van Eeckhout, P., Longton, E., Magremanne, M., Schmitz, S., Limaye, N., Machiels, J-P.
Publikováno v:
In Annals of Oncology October 2023 34 Supplement 2:S556-S557
Autor:
van Everdink, W.J, Baranova, A, Lummen, C, Tyazhelova, T, Looman, M.W.G, Ivanov, D, Verlind, E, Pestova, A, Faber, H, van der Veen, A.Y, Yankovsky, N, Vellenga, E, Buys, C.H.C.M
Publikováno v:
In Cancer Genetics and Cytogenetics 2003 146(1):48-57
Confusion remains a frequent event appearing during cancer course; many causes have to be excluded, including antitumoral agent-induced encephalopathy. Ifosfamide-induced encephalopathy is often underdiagnosed due to aspecific symptoms. The manifesta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::afe6203ac38aa24fb0aebcd1e0e943b0
https://doi.org/10.31487/j.cor.2018.10.009
https://doi.org/10.31487/j.cor.2018.10.009
Autor:
Galot, R. 1, Van Marcke de Lummen, C. 2, Helaers, R. 3, Mendola, A. 4, Goebbels, R.-M. 4, Caignet, X. 4, Ambroise, J. 5, Wittouck, K. 4, Vikkula, M. 3, Limaye, N. 6, Machiels, J.-P. 7
Publikováno v:
In Annals of Oncology October 2019 30 Supplement 5:v468-v469
Publikováno v:
British Journal of Pharmacology, 131(1), 99-107. Wiley-Blackwell
1 In the present study we investigated a possible role for the p38 mitogen-activated protein (MAP) kinase pathway in mediating nuclear factor-kappa B (NF-kappa B) transcriptional activity in the erythroleukaemic cell line TF-1. 2 TF-1 cells stimulate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::f5403ca48c1a8b7b7af435d6dda87976
https://research.rug.nl/en/publications/0a645f3b-8fa8-496f-be5d-3ee0cbf83ff8
https://research.rug.nl/en/publications/0a645f3b-8fa8-496f-be5d-3ee0cbf83ff8